211 related articles for article (PubMed ID: 34298867)
1. The Hexosamine Biosynthetic Pathway as a Therapeutic Target after Cartilage Trauma: Modification of Chondrocyte Survival and Metabolism by Glucosamine Derivatives and PUGNAc in an Ex Vivo Model.
Riegger J; Baumert J; Zaucke F; Brenner RE
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298867
[TBL] [Abstract][Full Text] [Related]
2. N-butyryl glucosamine increases matrix gene expression by chondrocytes.
Poustie MW; Carran J; McEleney K; Dixon SJ; Anastassiades TP; Bernier SM
J Pharmacol Exp Ther; 2004 Nov; 311(2):610-6. PubMed ID: 15240824
[TBL] [Abstract][Full Text] [Related]
3. The Hexosamine Biosynthesis Pathway: Regulation and Function.
Paneque A; Fortus H; Zheng J; Werlen G; Jacinto E
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107691
[TBL] [Abstract][Full Text] [Related]
4. The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies.
Lam C; Low JY; Tran PT; Wang H
Cancer Lett; 2021 Apr; 503():11-18. PubMed ID: 33484754
[TBL] [Abstract][Full Text] [Related]
5. Hexosamine biosynthetic pathway activity in leptin resistant sucrose-drinking rats.
Harris RB; Apolzan JW
Physiol Behav; 2015 Jan; 138():208-18. PubMed ID: 25446204
[TBL] [Abstract][Full Text] [Related]
6. Acute regulation of cardiac metabolism by the hexosamine biosynthesis pathway and protein O-GlcNAcylation.
Laczy B; Fülöp N; Onay-Besikci A; Des Rosiers C; Chatham JC
PLoS One; 2011 Apr; 6(4):e18417. PubMed ID: 21494549
[TBL] [Abstract][Full Text] [Related]
7. O-GlcNAcylation-inducing treatments inhibit estrogen receptor α expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells.
Kanwal S; Fardini Y; Pagesy P; N'tumba-Byn T; Pierre-Eugène C; Masson E; Hampe C; Issad T
PLoS One; 2013; 8(7):e69150. PubMed ID: 23935944
[TBL] [Abstract][Full Text] [Related]
8. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
9. Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer.
Akella NM; Ciraku L; Reginato MJ
BMC Biol; 2019 Jul; 17(1):52. PubMed ID: 31272438
[TBL] [Abstract][Full Text] [Related]
10. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc.
Champattanachai V; Marchase RB; Chatham JC
Am J Physiol Cell Physiol; 2007 Jan; 292(1):C178-87. PubMed ID: 16899550
[TBL] [Abstract][Full Text] [Related]
11. Glucosamine and Silibinin Alter Cartilage Homeostasis through Glycosylation and Cellular Stresses in Human Chondrocyte Cells.
Hsu YP; Huang TH; Liu ST; Huang SM; Chen YC; Wu CC
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732122
[TBL] [Abstract][Full Text] [Related]
12. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
[TBL] [Abstract][Full Text] [Related]
13. Hexosamines, insulin resistance, and the complications of diabetes: current status.
Buse MG
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
[TBL] [Abstract][Full Text] [Related]
14. Hexosamines are unlikely to function as a nutrient-sensor in 3T3-L1 adipocytes: a comparison of UDP-hexosamine levels after increased glucose flux and glucosamine treatment.
Bosch RR; Pouwels MJ; Span PN; Olthaar AJ; Tack CJ; Hermus AR; Sweep CG
Endocrine; 2004 Feb; 23(1):17-24. PubMed ID: 15034192
[TBL] [Abstract][Full Text] [Related]
15. Comparison of glucose derivatives effects on cartilage degradation.
Phitak T; Pothacharoen P; Kongtawelert P
BMC Musculoskelet Disord; 2010 Jul; 11():162. PubMed ID: 20630114
[TBL] [Abstract][Full Text] [Related]
16. Glucosamine inhibits angiotensin II-induced cytoplasmic Ca2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine.
Nagy T; Champattanachai V; Marchase RB; Chatham JC
Am J Physiol Cell Physiol; 2006 Jan; 290(1):C57-65. PubMed ID: 16107505
[TBL] [Abstract][Full Text] [Related]
17. Effects of glucosamine sulfate on intracellular UDP-hexosamine and UDP-glucuronic acid levels in bovine primary chondrocytes.
Qu CJ; Jauhiainen M; Auriola S; Helminen HJ; Lammi MJ
Osteoarthritis Cartilage; 2007 Jul; 15(7):773-9. PubMed ID: 17320421
[TBL] [Abstract][Full Text] [Related]
18. Elevated glucose levels impair the WNT/β-catenin pathway via the activation of the hexosamine biosynthesis pathway in endometrial cancer.
Zhou F; Huo J; Liu Y; Liu H; Liu G; Chen Y; Chen B
J Steroid Biochem Mol Biol; 2016 May; 159():19-25. PubMed ID: 26923859
[TBL] [Abstract][Full Text] [Related]
19. O-linked N-acetylglucosamine (O-GlcNAc) protein modification is increased in the cartilage of patients with knee osteoarthritis.
Tardio L; Andrés-Bergós J; Zachara NE; Larrañaga-Vera A; Rodriguez-Villar C; Herrero-Beaumont G; Largo R
Osteoarthritis Cartilage; 2014 Feb; 22(2):259-63. PubMed ID: 24333294
[TBL] [Abstract][Full Text] [Related]
20. Hexosamine biosynthesis in keratinocytes: roles of GFAT and GNPDA enzymes in the maintenance of UDP-GlcNAc content and hyaluronan synthesis.
Oikari S; Makkonen K; Deen AJ; Tyni I; Kärnä R; Tammi RH; Tammi MI
Glycobiology; 2016 Jul; 26(7):710-22. PubMed ID: 26887390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]